Open original FDA record ↗Recall record
- FDA identifier
- Z-2924-2020
- Company in FDA record
- RANDOX LABORATORIES, LTD.
- FDA record creation date
- Aug 29, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Amylase AY3805 batch 480449 and Pancreatic Amylase AY3855 batch 480483 have failed to meet the quoted performance claims prior to expiry on 28th Sept 2020.
Source facts
- Action
- The consumers were sent a letter via email dated July 10, 2020. This notice instructs customers to The distributors and customers will be instructed to: -Discontinue use of batches listed above immediately -Review your reagent inventory of these products and assess your laboratories needs for replacements. Proof of remaining kits will be required. -Discuss the contents of this notice with your Medical Director. -Complete and return the response form
- Initiated
- 2020-07-10
- Root cause
- Under Investigation by firm
- Terminated
- 2021-06-17
- Distribution
- New Mexico, Massachusetts, WV. Foreign distribution to Bolivia BOSNIA AND HERZEGOVINA Brazil Colombia Costa Rica Cyprus Egypt France Greece Grenada India Iraq Italy Jordan Kazakhstan Kenya Lithuania Mauritius Nepal Nigeria Pakistan Peru Philippines Poland Portugal Qatar Romania Russia South Africa Thailand The Bahamas Turkey UAE UK Vietnam
- Recall number
- Z-2924-2020
- Recall status
- Terminated
- CDRH record ID
- 182681
- FDA record created
- 2020-08-29
- Recall event number
- 86114